Japan Set To Order J&J To Cease Manipulation Of Contact-Lens Pricing
This article was originally published in PharmAsia News
Japanese authorities are expected to order U.S.-based Johnson & Johnson to cease pressuring the nation's large retailers to manipulating contact-lens prices in advertisements
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.